2023年4月4日 · Erlotinib (Tarceva) is a type of targeted therapy used to treat pancreatic cancer and non-small cell lung cancer. It is a tyrosine kinase inhibitor that works by blocking the …

Erlotinib, sold under the brand name Tarceva among others, is a medication used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer. [4] Specifically it is used for NSCLC …

2020年3月18日 · Erlotinib is a tyrosine kinase receptor inhibitor approved by the US Food and Drug Administration (FDA) for the treatment of non-small cell lung cancer and advanced …

On October 18, 2016, the U.S. Food and Drug Administration modified the indication for erlotinib (TARCEVA, Astellas Pharm Global Development Inc.) for treatment of non-small cell lung …

2025年3月1日 · Erlotinib is used for the treatment of metastatic (cancer that has already spread) non-small cell lung cancer in patients who have certain types of abnormal epidermal growth …

This page contains brief information about erlotinib hydrochloride and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

Erlotinib is an inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase that is used in the treatment of non-small cell lung cancer, pancreatic cancer and several other types of …

Erlotinib is a medication that stops cancer cells from growing. It treats non-small cell lung cancer and pancreatic cancer. Erlotinib comes in a tablet form that you can take by mouth with a …

Erlotinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of …

Erlotinib is used to treat lung and pancreatic cancer. It works by slowing or stopping the growth of cancer cells. Take this medication by mouth on an empty stomach (at least 1 hour...